drugset / Trial / NCT04008121
Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium
NaSingle-groupOpen-labelDiagnostic
Summary
The objective of this study is to evaluate the safety and image quality of the investigational dye, MB-102, compared to the control dye (fluorescein sodium) in healthy and diseased eyes using fluorescent angiography for retinal vascular disease diagnosis and monitoring.
Timeline
- Start
- 2025-11-06
- Primary completion
- 2026-12
- Completion
- 2026-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluorescein | Diagnostic / imaging agent | 500 mg | Intravenous |
| Subject | Relmapirazin | Diagnostic / imaging agent | 4 unknown | Intravenous |